ASTERASYS
Financials
Valuation Metrics
ASTERASYS's Market Cap is ₩1953B. At end of 2025 it was ₩4655B. Ranked #861 of 2,421 in KR market (top 36%), #403 of 1,640 on KOSDAQ (top 25%), #27 of 96 in Health Care Equipment & Services (top 28%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 195.29B KRW | KR#861/2,421 Sec#27/96 |
| Revenue | 39.61B KRW | KR#1,917/2,421 Sec#57/96 |
| Net Income | 6.09B KRW | KR#1,136/2,421 Sec#36/96 |
| Total Assets | 51.05B KRW | KR#2,199/2,421 Sec#74/96 |
| Net Assets | 45.22B KRW | KR#1,971/2,421 Sec#63/96 |
| Employees | 77 | KR#1,826/2,421 Sec#72/96 |
| Value | ||
| P/E | 32.09x | KR#1,324/2,421 Sec#43/96 |
| P/B | 4.32x | KR#2,210/2,421 Sec#85/96 |
| PEG | 0.45x | KR#678/2,421 Sec#26/96 |
| P/S | 4.93x | KR#2,143/2,421 Sec#74/96 |
| EV/EBITDA | 45.06x | KR#1,321/2,421 Sec#43/96 |
| FCF Yield | 1.81% | KR#1,068/2,421 Sec#31/96 |
| Profitability | ||
| ROE | 13.46% | KR#397/2,421 Sec#15/96 |
| ROA | 11.92% | KR#191/2,421 Sec#11/96 |
| Op. Margin | 10.76% | KR#479/2,421 Sec#27/96 |
| Revenue Growth | 31.60% | KR#369/2,421 Sec#19/96 |
| Earnings Growth | 72.09% | KR#463/2,421 Sec#23/96 |
| Financial Health | ||
| Debt Ratio | 12.90% | KR#206/2,421 Sec#14/96 |
| Total Debt | 1.00B KRW | KR#1,956/2,421 Sec#75/96 |
| FCF | 3.54B KRW | KR#990/2,421 Sec#27/96 |
| Cash | 4.33B KRW | KR#2,059/2,421 Sec#77/96 |
| Current Ratio | 7.56x | KR#157/2,421 Sec#14/96 |
| Net Debt/EBITDA | -0.78x | KR#425/2,421 Sec#14/96 |
| Dividend | ||
| Div. Yield | 2.03% | KR#868/2,421 Sec#22/96 |
| Div. Growth | 228.13% | KR#42/2,421 Sec#3/96 |
| Performance | ||
| 1Y Return | -58.78% | KR#2,187/2,421 Sec#81/96 |
| 1M Return | -1.52% | KR#1,423/2,421 Sec#43/96 |
| From 52W High | -70.31% | KR#2,197/2,421 Sec#82/96 |
| 1Y MDD | -69.32% | KR#1,964/2,421 Sec#70/96 |
| Trading | ||
| Volume | 9,534 shares | KR#1,933/2,421 Sec#79/96 |
| Trading Value | 49.3M KRW | KR#1,840/2,421 Sec#71/96 |
| Foreign Own. | 1.10% | KR#1,998/2,421 Sec#76/96 |
| Per Share | ||
| EPS | 162 KRW | KR#1,337/2,421 Sec#40/96 |
| BPS | 1,202 KRW | KR#2,260/2,421 Sec#85/96 |
Company Info
The company, Asterasys, established in 2015 for medical device manufacturing, is a small and medium-sized venture listed on KOSDAQ in 2025. It manufactures and sells anti-aging skin beauty devices using high-intensity focused ultrasound and non-invasive high-frequency, with Liftera as its main product. By the end of 2023, three new products were developed through KOL collaboration, and Coolfase and Coolsoniq obtained MFDS product approval. The company targets the global market after securing US FDA certification in 2026. Asterasys was established in 2015 and is headquartered in Seongdong-gu, Seoul.